BRCA1 and breast cancer: Up to 30 % of ovarian cancer and TNBC patients show functional impairment of BRCA1/2 genes [3, 4] and women carrying BRCA1/2 germline mutations are at an increased risk of developing ovarian and breast cancer [5–8].